Global sales information of Levosimendan with Finished Drug Prices obtained from US Medicaid's National Average Drug Acquisition Cost

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

MARKET PLACE

FINISHED DOSAGE FORMULATIONS

0

FDA Orange Book

FDA (Orange Book)

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 141505-33-1, Simdax, (r)-simendan, (-)-or-1259, Or-1259, Simendan, (r)-
Molecular Formula
C14H12N6O
Molecular Weight
280.28  g/mol
InChI Key
WHXMKTBCFHIYNQ-SECBINFHSA-N
FDA UNII
C6T4514L4E

Levosimendan
A hydrazone and pyridazine derivative; the levo-form is a phosphodiesterase III inhibitor, calcium-sensitizing agent, and inotropic agent that is used in the treatment of HEART FAILURE.
1 2D Structure

Levosimendan

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[[4-[(4R)-4-methyl-6-oxo-4,5-dihydro-1H-pyridazin-3-yl]phenyl]hydrazinylidene]propanedinitrile
2.1.2 InChI
InChI=1S/C14H12N6O/c1-9-6-13(21)19-20-14(9)10-2-4-11(5-3-10)17-18-12(7-15)8-16/h2-5,9,17H,6H2,1H3,(H,19,21)/t9-/m1/s1
2.1.3 InChI Key
WHXMKTBCFHIYNQ-SECBINFHSA-N
2.1.4 Canonical SMILES
CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N
2.1.5 Isomeric SMILES
C[C@@H]1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N
2.2 Other Identifiers
2.2.1 UNII
C6T4514L4E
2.3 Synonyms
2.3.1 MeSH Synonyms

1. ((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)propanedinitrile

2. Dextrosimendan

3. Or 1259

4. Or 1855

5. Or-1259

6. Or-1855

7. Simadax

8. Simendan

2.3.2 Depositor-Supplied Synonyms

1. 141505-33-1

2. Simdax

3. (r)-simendan

4. (-)-or-1259

5. Or-1259

6. Simendan, (r)-

7. Chebi:50567

8. 2-[[4-[(4r)-4-methyl-6-oxo-4,5-dihydro-1h-pyridazin-3-yl]phenyl]hydrazinylidene]propanedinitrile

9. Nsc-759644

10. Levosimedan

11. C6t4514l4e

12. Or1259

13. (r)-((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono) Propanedintrile

14. (r)-n-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)carbonohydrazonoyl Dicyanide

15. Levosimendan [inn]

16. Dsstox_cid_26445

17. Dsstox_rid_81620

18. Mesoxalonitrile (p-((r)-1,4,5,6-tetrahydro-4-methyl-6-oxo-pyridazinyl)phenyl)hydrazone

19. Dsstox_gsid_46445

20. Levosimendanum

21. Smr002529692

22. Simdax (tn)

23. Cas-141505-33-1

24. Levosimendan (usan/inn)

25. Levosimendan [usan:inn]

26. Or 1259

27. Unii-c6t4514l4e

28. ((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)propanedinitrile

29. Levosimendan- Bio-x

30. Levosimendan [mi]

31. Levosimendan [usan]

32. Mesoxalonitrile (-)-(p((r)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazone

33. Schembl83243

34. Levosimendan [mart.]

35. Mls003899227

36. Mls006010741

37. Levosimendan [who-dd]

38. Chembl2051955

39. Dtxsid9046445

40. Levosimendan, >=98% (hplc)

41. Hms3264g03

42. Hms3884n17

43. Kuc109648n

44. Pharmakon1600-01502356

45. Act02710

46. Bcp07048

47. Zinc3915645

48. Tox21_112191

49. Tox21_113768

50. Bdbm50469700

51. Mfcd00867135

52. Nsc759644

53. S2446

54. Akos015895214

55. Tox21_112191_1

56. Ac-1752

57. Am84381

58. Ccg-213048

59. Db00922

60. Ds-8918

61. Nsc 759644

62. ({4-[(4r)-4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl]phenyl}hydrazono)propanedintrile

63. 2-[[4-[(4r)-4-methyl-6-oxo-4,5-dihydro-1h-pyridazin-3-yl]phenyl]hydrazono]propanedinitrile

64. Ksc-210-010

65. Ncgc00253641-01

66. Ncgc00263564-01

67. Ncgc00263564-02

68. Bm164625

69. Hy-14286

70. L0320

71. Sw219172-1

72. A11874

73. D04720

74. N12889

75. Ab01562970_01

76. Ab01562970_02

77. 741l087

78. A807767

79. Q162541

80. Sr-01000931342

81. Sr-01000931342-2

82. 1-beta-d-ribofuranose-1h-1,2,4-triazole-3-methylcarbonate

83. (r)-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)carbonohydrazonoyl Dicyanide

84. (r)-n-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)carbonohydrazonoyldicyanide

85. 1-cyano-n-{4-[(4r)-4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl]phenyl}methanecarbohydrazonoyl Cyanide

86. 2-(2-(4-((4r)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazinylidene)propanedinitrile

87. Mesoxalonitrile (-)-(p((r)-1,4,5,6-tetrahydro-4-methyl-6- Oxo-3-pyridazinyl)phenyl)hydrazone

88. Propanedinitrile, ((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono)-, (r)-

89. Propanedinitrile, 2-(2-(4-((4r)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazinylidene)-

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 280.28 g/mol
Molecular Formula C14H12N6O
XLogP32.3
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count3
Exact Mass280.10725903 g/mol
Monoisotopic Mass280.10725903 g/mol
Topological Polar Surface Area113 Ų
Heavy Atom Count21
Formal Charge0
Complexity549
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

For short term treatment of acutely decompensated severe chronic heart failure (CHF). Also being investigated for use/treatment in heart disease.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Levosimendan is a new Ca2+-sensitizing inotropic agent. Ca2+ sensitizers represent a new class of inotropic agents, which overcome the disadvantages associated with currently available inotropic agents in as they are not associated with an increased risk of arrhythmias, cell injury and death due to Ca2+ overload in myocardial cells; they do not increase the activation energy; and they have the potential to reverse contractile dysfunction under pathophysiologic conditions, such as acidosis or myocardial stunning. Levosimendan has not been approved for use in the U.S. or Canada.


5.2 MeSH Pharmacological Classification

Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)


Cardiotonic Agents

Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)


Phosphodiesterase 3 Inhibitors

Compounds that specifically inhibit PHOSPHODIESTERASE 3. (See all compounds classified as Phosphodiesterase 3 Inhibitors.)


5.3 ATC Code

C - Cardiovascular system

C01 - Cardiac therapy

C01C - Cardiac stimulants excl. cardiac glycosides

C01CX - Other cardiac stimulants

C01CX08 - Levosimendan


5.4 Absorption, Distribution and Excretion

Absorption

The bioavailability of oral levosimendan is 85 ± 6% in healthy volunteers and 84 ± 4% in patients.


5.5 Metabolism/Metabolites

Complete metabolism, with some active metabolites (OR-1855 and OR-1896) possibly extending the drug's haemodynamic effects.


5.6 Biological Half-Life

Eliminination half-life is approximately 1 hour.


5.7 Mechanism of Action

Levosimendan appears to increase myofilament calcium sensitivity by binding to cardiac troponin C in a calcium-dependent manner. This stabilizes the calcium-induced conformational change of troponin C, thereby (1) changing actin-myosin cross-bridge kinetics apparently without increasing the cycling rate of the cross-bridges or myocardial ATP consumption, (2) increasing the effects of calcium on cardiac myofilaments during systole and (3) improving contraction at low energy cost (inotropic effect). Calcium concentration and, therefore, sensitization decline during diastole, allowing normal or improved diastolic relaxation. Levosimendan also leads to vasodilation through the opening of ATP-sensitive potassium channels. By these inotropic and vasodilatory actions, levosimendan increases cardiac output without increasing myocardial oxygen demand. Levosimendan also has a selective phosphodiesterase (PDE)-III inhibitory action that may contribute to the inotropic effect of this compound under certain experimental conditions. It has been reported that levosimendan may act preferentially as a Ca2+ sensitizer at lower concentrations, whereas at higher concentrations its action as a PDE-III inhibitor becomes more prominent in experimental animals and humans.


API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"LEVOSIMENDAN","year":"2021","qtr":"Q1","strtotime":1612463400,"product":"LEVOSIMENDAN","address":"MALVA,UNIT NO.108,PATANWALA ESTATE,L.B.S. MARG, GHATKOPAR WEST,","city":"MUMBAI ,MAHARASHTRA","supplier":"PRECISE GROUP","supplierCountry":"INDIA","foreign_port":"TALLINN","customer":"INTERCHEMIE WERKEN DE ","customerCountry":"ESTONIA","quantity":"0.03","actualQuantity":"25","unit":"GMS","unitRateFc":"342.1","totalValueFC":"8464.1","currency":"USD","unitRateINR":24649.68,"date":"05-Feb-2021","totalValueINR":"616242","totalValueInUsd":"8464.1","indian_port":"BOMBAY AIR","hs_no":"29339990","bill_no":"8434828","productDescription":"API","marketType":"REGULATED MARKET","country":"ESTONIA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"MALVA,UNIT NO.108,PATANWALA ESTATE,L.B.S. MARG, GHATKOPAR WEST,, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1626028200,"product":"LEVOSIMENDAN GRADE:IH","address":"FLAT,NO.505, 5TH FLR.,UNIQUE TOWER,S.V.ROAD,NR.KAMATH CLUB,GOREGAON(W)","city":"MUMBAI, MAHARASHTRA","supplier":"MELODY HEALTHCARE PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"SHIPPER","customerCountry":"TURKEY","quantity":"0.01","actualQuantity":"0.01","unit":"KGS","unitRateFc":"494165.2","totalValueFC":"4777.4","currency":"USD","unitRateINR":35604600,"date":"12-Jul-2021","totalValueINR":"356046","totalValueInUsd":"4777.4","indian_port":"BOMBAY AIR","hs_no":"29334900","bill_no":"3057416","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"FLAT,NO.505, 5TH FLR.,UNIQUE TOWER,S.V.ROAD,NR.KAMATH CLUB,GOREGAON(W), MUMBAI, MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1635791400,"product":"LEVOSIMENDAN GRADE: IH","address":"FLAT,NO.505, 5TH FLR.,UNIQUE TOWER,S.V.ROAD,NR.KAMATH CLUB,GOREGAON(W)","city":"MUMBAI, MAHARASHTRA","supplier":"MELODY HEALTHCARE PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"KIEV","customer":"SHIPPER","customerCountry":"UKRAINE","quantity":"0.17","actualQuantity":"0.168","unit":"KGS","unitRateFc":"515000","totalValueFC":"85710.9","currency":"USD","unitRateINR":37994047.619047619,"date":"02-Nov-2021","totalValueINR":"6383000","totalValueInUsd":"85710.9","indian_port":"BOMBAY AIR","hs_no":"29334900","bill_no":"5772152","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"UKRAINE","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"FLAT,NO.505, 5TH FLR.,UNIQUE TOWER,S.V.ROAD,NR.KAMATH CLUB,GOREGAON(W), MUMBAI, MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1659465000,"product":"LEVOSIMENDAN GRADE : IH","address":"FLAT NO.1003,10TH FLR,UNIQUE TOWER ,,S.V.ROAD,NR.KAMATH CLUB,GOREGAON","city":"MUMBAI,MAHARASHTRA","supplier":"MELODY HEALTHCARE PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"ANKARA","customer":"TO THE ORDER OF","customerCountry":"TURKEY","quantity":"0.03","actualQuantity":"0.033","unit":"KGS","unitRateFc":"500000","totalValueFC":"16300.7","currency":"USD","unitRateINR":39303030.303030305,"date":"03-Aug-2022","totalValueINR":"1297000","totalValueInUsd":"16300.7","indian_port":"BOMBAY AIR","hs_no":"29334900","bill_no":"3263035","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"FLAT NO.1003,10TH FLR,UNIQUE TOWER ,,S.V.ROAD,NR.KAMATH CLUB,GOREGAON, MUMBAI,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1662057000,"product":"LEVOSIMENDAN IH API BATCH NO: LSM\/22001","address":"CAMUS HOUSE, 29-B, SURAJ NAGAR EAST, CIVIL LINES,","city":"JAIPUR, RAJASTHAN.","supplier":"CAMUS PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"PSK PHARMA LTD.","customerCountry":"RUSSIA","quantity":"0.03","actualQuantity":"0.033","unit":"KGS","unitRateFc":"547000","totalValueFC":"17494.2","currency":"USD","unitRateINR":42484848.484848484,"date":"02-Sep-2022","totalValueINR":"1402000","totalValueInUsd":"17494.2","indian_port":"BOMBAY AIR","hs_no":"29334900","bill_no":"3922250","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CAMUS HOUSE, 29-B, SURAJ NAGAR EAST, CIVIL LINES,, JAIPUR, RAJASTHAN.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1700764200,"product":"PHARMA.RAW MATERIAL,ACTIVE PHARMA INGREDIENT, PAC.DETAILS: 1 X 0.035KGS LEVOSIMENDAN ICH GRADE: IH","address":"FLAT,NO.505, 5TH FLR.,UNIQUE TOWER,","city":"MUMBAI, MAHARASHTRA","supplier":"MELODY HEALTHCARE PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"ANKARA","customer":"AS PER INVOICE","customerCountry":"TURKEY","quantity":"0.04","actualQuantity":"0.035","unit":"KGS","unitRateFc":"425000","totalValueFC":"14643.1","currency":"USD","unitRateINR":34742857.142857142,"date":"24-Nov-2023","totalValueINR":"1216000","totalValueInUsd":"14643.1","indian_port":"Bombay Air","hs_no":"29334900","bill_no":"5540241","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"FLAT,NO.505, 5TH FLR.,UNIQUE TOWER,, MUMBAI, MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706121000,"product":"PHARMA.RAW MATERIAL, ACTIVE PHARMA INGREDIENT, PACKING DETAILS: 1 X 0.050 KGS LEVOSIMENDAN GRADE: IH CAS NO:141505-33-1","address":"FLAT,NO.505, 5TH FLR.,UNIQUE TOWER,","city":"MUMBAI, MAHARASHTRA","supplier":"MELODY HEALTHCARE PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"ISTANBUL","customer":"AS PER INVOICE","customerCountry":"TURKEY","quantity":"0.05","actualQuantity":"0.05","unit":"KGS","unitRateFc":"350000","totalValueFC":"17265.6","currency":"USD","unitRateINR":28675660,"date":"25-Jan-2024","totalValueINR":"1433783","totalValueInUsd":"17265.6","indian_port":"Bombay Air","hs_no":"29334900","bill_no":"7033413","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"TURKEY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"FLAT,NO.505, 5TH FLR.,UNIQUE TOWER,, MUMBAI, MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1706293800,"product":"PHARMA.RAW MATERIAL, ACTIVE PHARMA INGREDIENT, PACKING DETAILS:1 X 0.060 KGS LEVOSIMENDAN GRADE: IH CAS NO: 141505-33-1","address":"FLAT,NO.505, 5TH FLR.,UNIQUE TOWER,","city":"MUMBAI, MAHARASHTRA","supplier":"MELODY HEALTHCARE PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"FRANKFURT\/MAIN INT\\'L","customer":"AS PER INVOICE","customerCountry":"GERMANY","quantity":"0.06","actualQuantity":"0.06","unit":"KGS","unitRateFc":"460000","totalValueFC":"27257.6","currency":"USD","unitRateINR":37725750,"date":"27-Jan-2024","totalValueINR":"2263545","totalValueInUsd":"27257.6","indian_port":"Bombay Air","hs_no":"29334900","bill_no":"7058478","productDescription":"API","marketType":"REGULATED MARKET","country":"GERMANY","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"FLAT,NO.505, 5TH FLR.,UNIQUE TOWER,, MUMBAI, MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1714761000,"product":"LEVOSIMENDAN GRADE: IH BATCH NO. 1SM\/22004","address":"CAMUS HOUSE, 29-B,","city":"JAIPUR, RAJASTHAN.","supplier":"CAMUS PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"PSK PHARMA LTD.","customerCountry":"RUSSIA","quantity":"0.06","actualQuantity":"0.058","unit":"KGS","unitRateFc":"42100000","totalValueFC":"29060.9","currency":"INR","unitRateINR":41608510.344827585,"date":"04-May-2024","totalValueINR":"2413293.6","totalValueInUsd":"29060.9","indian_port":"Bombay Air","hs_no":"29334900","bill_no":"9618920","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"CAMUS HOUSE, 29-B,, JAIPUR, RAJASTHAN.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1714761000,"product":"LEVOSIMENDAN GRADE: IH BATCH NO. 1SM\/22004","address":"CAMUS HOUSE, 29-B,","city":"JAIPUR, RAJASTHAN.","supplier":"CAMUS PHARMA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"PSK PHARMA LTD.","customerCountry":"RUSSIA","quantity":"0.06","actualQuantity":"0.058","unit":"KGS","unitRateFc":"42100000","totalValueFC":"29060.9","currency":"INR","unitRateINR":41608510.344827585,"date":"04-May-2024","totalValueINR":"2413293.6","totalValueInUsd":"29060.9","indian_port":"Bombay Air","hs_no":"29334900","bill_no":"9626882","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"CAMUS HOUSE, 29-B,, JAIPUR, RAJASTHAN.","customerAddress":""}]
05-Feb-2021
04-May-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty